LON:4BB

4basebio (4BB) Share Price, News & Analysis

4basebio logo
GBX 517.50 -7.50 (-1.43%)
As of 03:14 AM Eastern

About 4basebio Stock (LON:4BB)

Advanced

Key Stats

Today's Range
517.50
▼
525
50-Day Range
475.55
▼
568.50
52-Week Range
420
▼
725
Volume
56 shs
Average Volume
1,253 shs
Market Capitalization
£80.13 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 1,400
Consensus Rating
Buy

Company Overview

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients. Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.

4basebio Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
23rd Percentile Overall Score

4BB MarketRank™: 
1.16420098627 of 5 stars

4basebio scored higher than 23% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    4basebio has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and no sell ratings.

  • Upside Potential

    4basebio has a consensus price target of GBX 1,400, representing about 180.0% upside from its current price of GBX 500.

  • Amount of Analyst Coverage

    4basebio has received no research coverage in the past 90 days.

  • Read more about 4basebio's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of 4basebio is -4.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of 4basebio is -4.31, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Short Interest

    There is no current short interest data available for 4BB.
  • Dividend Yield

    4basebio does not currently pay a dividend.

  • Dividend Growth

    4basebio does not have a long track record of dividend growth.

  • News Coverage This Week

    MarketBeat has tracked 1 news article for 4basebio this week, compared to 1 article on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, 4basebio insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    12.09% of the stock of 4basebio is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    0.90% of the stock of 4basebio is held by institutions.

  • Read more about 4basebio's insider trading history.
Receive 4BB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 4basebio and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

4BB Stock News Headlines

4basebio: Turning clinical credibility into commercial growth
A $247 tool for $7
Bill Poulos is offering his $247 Instant Scanner for $7 in the Black Friday sale. It's one payment for a full year, with no re-bills and nothing to install. The catch? He isn't trying to profit on the scanner itself. Poulos is betting that once you see it deliver the night's list, you'll want more of his work for years.tc pixel
4basebio Plc - Result of General Meeting
4basebio Plc - Result of General Meeting
4basebio Plc - Result of Retail Offer
See More Headlines

4BB Stock Analysis - Frequently Asked Questions

4basebio's stock was trading at GBX 600 at the beginning of 2026. Since then, 4BB stock has decreased by 16.7% and is now trading at GBX 500.

4basebio PLC (LON:4BB) announced its quarterly earnings data on Monday, September, 28th. The company reported GBX (0.57) earnings per share for the quarter.

Shares of 4BB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Company Calendar

Last Earnings
9/28/2026
Today
11/18/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
LON:4BB
CIK
N/A
Fax
N/A
Employees
101
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 1,400
Low Price Target
GBX 1,400
Potential Upside/Downside
+180.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX (116)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£9.84 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-231.29%
Return on Assets
-54.30%

Debt

Debt-to-Equity Ratio
201.47
Current Ratio
2.73
Quick Ratio
3.52

Sales & Book Value

Annual Sales
£781 thousand
Price / Sales
99.14
Cash Flow
GBX 31.10 per share
Price / Cash Flow
16.08
Book Value
GBX (41) per share
Price / Book
-12.20

Miscellaneous

Outstanding Shares
15,485,000
Free Float
N/A
Market Cap
£77.43 million
Optionable
Not Optionable
Beta
1.09
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (LON:4BB) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners